ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB)
CUSIP: 045396207
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per shares (the "Shares")
- Shares outstanding
- 15,738,333
- Total 13F shares
- 1,175,256
- Share change
- +527,973
- Total reported value
- $16,110,171
- Price per share
- $13.72
- Number of holders
- 27
- Value change
- +$7,242,756
- Number of buys
- 15
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 045396207?
CUSIP 045396207 identifies ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 045396207:
Top shareholders of ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
196,368
|
$2,611,694 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.79%
|
124,922
|
$1,661,463 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.5%
|
77,961
|
$1,036,882 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
52,197
|
$694,371 | — | 31 Mar 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.32%
|
49,732
|
$661,436 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.25%
|
39,460
|
$525,000 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.16%
|
25,394
|
$337,740 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
14,500
|
$192,850 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
12,109
|
$161,050 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.07%
|
11,318
|
$150,529 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
10,559
|
$140,435 | — | 31 Mar 2024 | |
| Marquette Asset Management, LLC |
13F
|
Company |
0.06%
|
9,016
|
$119,913 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.05%
|
7,934
|
$105,760 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
5,868
|
$78,000 | — | 31 Mar 2024 | |
| Michael P. Samar |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
77,228
|
$61,782 | — | 25 Jul 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
3,235
|
$43,026 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
2,994
|
$39,820 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
2,472
|
$32,877 | — | 31 Mar 2024 | |
| Luisa M. Stamm |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
152,815
mixed-class rows
|
$32,252 | — | 29 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
857
|
$11,398 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
199
|
$2,646 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
79
|
$1,000 | — | 31 Mar 2024 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0%
|
55
|
$686 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
44
|
$585 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
7
|
$93 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
3
|
$40 | — | 31 Mar 2024 | |
| Richard D. DiMarchi |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 25 May 2022 | |
| Myron Z. Holubiak |
3/4/5
|
Director |
—
class O/S missing
|
15,000
|
— | — | 20 May 2021 |
Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock, par value $0.001 per shares (the "Shares") (ASMB) as of Q2 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.